Four Portfolio Companies of Oriza Holdings Selected for Suzhou’s 2024 Major Scientific and Technological Achievements Transformation 'Challenge-Response' Program
SceneRay
Innovative High-Tech Medical Device R&D and Manufacturer
Recently, the list of proposed projects for the 2024 Suzhou Major Scientific and Technological Achievements Transformation "Challenge Leader" program was released, featuring four invested companies of Yuanhe Holdings.
List of Selected Projects for the 2024 Suzhou Major Scientific and Technological Achievements Transformation "Challenge Leader" Program (Companies Invested by Yuanhe Holdings)
Strong Semiconductor
Strong Semiconductor is a high-tech enterprise specializing in the research, development, and production of integrated circuit testing interface equipment. It has gathered a group of technical talents from the probe card industry and is the first company in China to achieve the research, development, and mass production of high-end MEMS probe cards. The company consistently focuses on customer needs, continuously innovates, and is committed to becoming a world-class provider of integrated solutions for integrated circuit testing interfaces.
Crystal Clear Technology
Crystal Semiconductor Technology is a service provider dedicated to developing innovative technologies for mass production of semiconductor packaging, offering customers reliable, miniaturized, high-performance, and cost-effective solutions. Crystal Semiconductor Technology's CMOS image sensor wafer-level packaging technology has made high-performance, compact mobile camera modules possible. This value proposition has made it the most widely used packaging technology in history, with nearly 50% of image sensor chips now utilizing this technology, extensively applied in various electronic products such as smartphones, tablets, and wearable electronics.
Sceneray
Sceneray is an innovative high-tech medical device enterprise that integrates research and development, production, and sales. For many years, it has been deeply engaged in the field of deep brain stimulation therapy while leading the frontier exploration of invasive brain-computer interfaces for medical use. Adhering to the mission of applying brain science research to medical scenarios and enabling more patients to benefit from advanced medical technology treatments, Sceneray has consistently remained at the forefront of the industry, achieving significant breakthroughs in the treatment of Parkinson’s disease, drug addiction, and other conditions.
Ascentage Pharma
Ascentage Pharma is a comprehensive global biopharmaceutical company dedicated to developing first-in-class and best-in-class drugs to address unmet clinical needs for patients worldwide in areas such as hematological malignancies. It has established a pipeline of 9 novel small-molecule drugs that have entered clinical development, making it the only innovative company globally with clinical-stage compounds targeting key proteins in the apoptosis pathway.